0
Deep & Emerging Tech·October 18, 2026·1 min read

Biotech now sells pet cloning and cryonics, MIT Technology Review finds

Share

Pet cloning, longevity drugs, and cryonics are normalizing high-priced, emotionally driven biotech purchases long before similar offerings go mainstream for humans. For operators in biotech and insurance, this is a live testbed for pricing, regulation, and ethics frameworks around elective life-extension services.

Deep & Emerging Tech

RegLayer: 47+ large US data center projects were delayed, withdrawn, or blocked in 2026; Bernstein says ~35% of the planned US data center pipeline is credible

If only ~35% of the US data center pipeline is credible and 47+ large projects were delayed or blocked, your AI roadmap is now constrained by permitting, power, and local politics as much as by GPUs. Treat site selection, regulatory risk, and grid access as first-class inputs to any multi-year AI capacity plan.